Advanced Discussion on Bioidentical Hormone Therapy, Compounded Dosage Forms, and Patient Care
Following the overwhelming response to Women’s HRT Compounding 101, Belmar Medical Director, Angela DeRosa, DO, MBA, CPE, and Andi Roths, PharmD, Director of Women’s Health, return for an in-depth clinical discussion addressing many of the questions healthcare providers have about women’s hormonal health and compounded bioidentical hormone replacement therapy (BHRT). Building on the foundational webinar, this session reviews clinical considerations for selecting appropriate compounded dosage forms and discusses approaches to individualized hormone therapy across different stages of women’s health.
What You’ll Learn
Dr. DeRosa and Andi Roths review the wide range of compounded therapies available for women’s health, including:
- Oral tablets and capsules
- Fast-burst sublingual tablets
- Troches
- Topical and vaginal creams
- Suppositories
- Nasal sprays
- Hair formulations
- Pellets
- Sterile Injectables
They explain the unique advantages, potential limitations, and clinical considerations of each dosage form, while discussing how individualized compounding provides additional flexibility in dosage form selection and formulation based on specific patient needs and provider preferences.
Additional topics include:
- Vaginal health
- Sexual wellness
- Metabolic support & weight management
- Skin health
- Thyroid therapy
- Longevity-focused therapies
Practical Pearls for Personalized Women’s Hormone Therapy
Throughout the webinar, Dr. DeRosa shares valuable prescribing insights drawn from decades of clinical experience, including when to select systemic versus localized hormone therapy, appropriate use of oral progesterone for endometrial protection, strategies for minimizing hormone transfer with topical preparations, and considerations for choosing pellets, creams, sublingual therapies, or other delivery methods.
The presenters also discuss how partnering with an experienced compounding pharmacy allows providers to customize strengths, dosage forms, and combinations that are not commercially available, supporting individualized therapy approaches for women throughout reproductive life, perimenopause, menopause, and beyond.
Whether you are expanding your knowledge of BHRT or looking for practical answers to common prescribing questions, this webinar provides evidence-informed guidance to help you confidently integrate compounded hormone therapy into your women’s health practice.
This webinar is intended for providers seeking a broader understanding of women’s HRT compounding options and the clinical considerations associated with personalized hormone therapy.
If you are a provider and would like to watch the webinar, please fill out the form below.
